A novel fluorescence-based cellular permeability assay

Vascular permeability is a pathologic process in many disease states ranging from metastatic progression of malignancies to ischemia–reperfusion injury. In order to more precisely study tissue, and more specifically cell layer permeability, our goal was to create a fluorescence-based assay which could quantify permeability without radioactivity or electrical impedance measurements. Human aortic endothelial cells were grown in monolayer culture on Costar®-Transwell® clear polyester membrane 6-well cell culture inserts. After monolayer integrity was confirmed, vascular endothelial growth factor (VEGF165) at varying concentrations with a fixed concentration of yellow-green fluorescent 0.04 μm carboxylate-modified FluoSpheres® microspheres were placed in the luminal chamber and incubated for 24 h. When stimulated with VEGF165 at 20, 40, 80, and 100 ng/ml, this assay system was able to detect increases in trans-layer flux of 8.2 ± 2.4%, 16.0 ± 3.7%, 41.5 ± 4.9%, and 58.6 ± 10.1% for each concentration, respectively. This represents the first fluorescence-based permeability assay with the sensitivity to detect changes in the permeability of a cell layer to fluid flux independent of protein flux; as well as being simpler and safer than previous radioactive-and impedance-based permeability assays. With the application of this in vitro assay to a variety of pathologic conditions, both the dynamics and physiology relating to cellular permeability can be more fully investigated.